| Patient | Sigmund Freud |
|---|---|
| Date of birth | 1856-05-06 |
| Identifiers | MRN HR-ET005-SYN-TD; SSN (made up) 000-05-8403 |
| Document date | 1930-08-24 |
| Author | Anton Reinholt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twelve-week review: five weeks without smoking and the new obturator. [S]
Mr. Freud returns twelve weeks after intake. He stopped smoking on his quit date five weeks ago. In the second week he smoked one cigar after a dinner with colleagues, felt worse for it, and has not smoked since; he did not treat it as a reason to give up. He uses the 21 mg patch each morning and three to five lozenges a day, and takes varenicline 1 mg twice daily. He sleeps well and his mood is steady. Dr. Vasquez-Lindqvist fitted the new obturator this morning, and with it there is no nasal leakage. He has had four speech-language therapy sessions since the last visit. His head and neck surgeon's yearly examination two weeks ago, with flexible endoscopy, found no recurrence and no second cancer. His pain is 3 of 10. [S]
| Element | Detail |
|---|---|
| Tobacco | No smoking for five weeks except one cigar in the second week |
| Treatment | Varenicline 1 mg twice daily; 21 mg patch; three to five lozenges a day |
| New obturator | Fitted this morning; no nasal leakage |
| Surveillance | Surgeon's yearly examination two weeks ago: no recurrence |
| Pain | 3 of 10 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up; appetite better since stopping smoking |
| Ears, nose, mouth, and throat | Negative | No nasal leakage with the new obturator; no sore, lump or bleeding |
| Respiratory | Negative | Morning cough almost gone |
| Psychiatric | Negative | Mood steady; cravings brief and manageable |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days | One tablet daily for three days, then twice daily for four days, after food | Oral route | 1930-06-01 to 1930-06-08 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks | One tablet twice daily after food | Oral route | 1930-06-08 | active | S |
| Nicotine 21 mg/24 hours transdermal patch, one patch each morning from the quit date, for six weeks | One patch each morning | Topical route | 1930-07-20 to 1930-08-31 | completed | S |
| Nicotine 4 mg oral lozenge, one lozenge as needed for cravings, up to 10 a day, dissolved on the side away from the obturator; gum avoided because it sticks to the prosthesis | One lozenge as needed, up to 10 a day | Oral route | 1930-07-20 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site | Two tablets three times daily | Oral route | 1930-06-01 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1930-08-24 | Body height | 172 | cm | S |
| 1930-08-24 | Body weight | 59.8 | kg | S |
| 1930-08-24 | Body mass index (BMI) [Ratio] | 20.2 | kg/m2 | S |
| 1930-08-24 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1930-08-24 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1930-08-24 | Heart rate | 70 | /min | S |
| 1930-08-24 | Respiratory rate | 14 | /min | S |
| 1930-08-24 | Body temperature | 36.7 | Cel | S |
| 1930-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1930-08-24 | Albumin [Mass/volume] in Serum or Plasma | 3.7 | g/dL | 3.5-5 g/dL | Normal | S |
| 1930-08-24 | Pain severity in the past week - 0-10 numeric rating [Reported] | 3 | {score} | S |
Vital signs recorded on 1930-08-24; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 132/78, pulse 70; weight 59.8 kg |
| Mouth | New obturator well seated; no pressure areas; mucosa healthy; no mass or white or red patch |
| Speech | Normal resonance with the obturator in |
| Skin | Mild redness at the last patch site only |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smoking | active | confirmed | F17.290 | S — Synthetic modern coding; person-first language; not a claim about his real diagnosis. |
| Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillance | active | confirmed | Z85.818 | S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic. |
| Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorly | active | confirmed | Z90.09 | S — Synthetic modern coding anchored to his documented obturator. |
| Hypernasal speech and nasal leakage of liquids from a poorly sealing obturator | resolved | confirmed | R49.21 | S — Synthetic finding; resolved when the new obturator was fitted. |
| Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubs | active | confirmed | G89.29 | S — Synthetic modern coding anchored to his documented constant mouth pain. |
| Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smoking | active | confirmed | E78.5 | S — Synthetic finding on the intake lipid panel. |
| Weight loss of 4 kg in six months from painful chewing and leakage, with a low albumin | active | confirmed | R63.4 | S — Synthetic finding; resolved as weight and albumin recovered. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Tobacco use (cigars a day), readiness and quit date | Every visit | Completed today | No smoking for five weeks except one cigar in the second week; exhaled carbon monoxide 4 ppm (narrative) |
| Medication safety | Varenicline adherence and side effects (nausea, sleep, dreams, mood) | Every visit; at least 12 weeks, extended to 24 weeks or more | Completed today | Taking it twice daily; no side effects now; extended to at least 24 weeks |
| Medication safety | Combination nicotine replacement (patch and lozenge) | From the quit date for at least 8 to 12 weeks | Completed today | 21 mg patch for six weeks, then 14 mg for four weeks; lozenges three to five a day; mild redness at patch sites |
| Self-management | Behavioral support (quitline and clinic sessions) | Weekly calls around the quit date, then every two to four weeks | Completed today | Weekly quitline calls around the quit date; now every two weeks |
| Self-management | Relapse prevention | Every visit | Completed today | The slip was reviewed without blame; plan for dinners and travel |
| Examination | Head and neck surveillance examination (mouth, defect and neck) | Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visit | Completed today | Surgeon's yearly examination with flexible endoscopy two weeks ago: no recurrence or second primary; mouth healthy today |
| Imaging | Head and neck imaging | Only for symptoms or signs more than five years after treatment | Not indicated | No symptoms or signs |
| Examination | Obturator fit, seal and hygiene | Every visit | Completed today | New definitive obturator fitted this morning by Dr. Vasquez-Lindqvist; good seal |
| Examination | Speech and swallowing (hypernasality, nasal leakage) | Every visit; speech-language therapy as needed | Completed today | Four therapy sessions since the corrective action; normal resonance with the new obturator |
| Examination | Weight and nutrition | Every visit | Completed today | 59.8 kg |
| Laboratory | Albumin | Baseline and at three months while weight is recovering | Completed today | Albumin 3.7 g/dL, from 3.4 |
| Survey | Pain score and function | Every visit | Completed today | 3 of 10, measured before the new obturator was fitted |
| Medication safety | Acetaminophen daily dose (no more than 3,000 mg) | Every visit | Completed today | 3,000 mg a day |
| Medication safety | Opioids | Avoid long-term opioids | Not indicated | Not needed |
Goal progress:
Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022)
Follow-up: Patch step-down from next week. Quitline every two weeks. Two more speech-language therapy sessions. Five-month review in nine weeks with blood count, albumin, kidney function and ALT. Next scheduled visit 1930-09-28: subsequent annual wellness visit. [S]